1. Home
  2. ALLK vs GNSS Comparison

ALLK vs GNSS Comparison

Compare ALLK & GNSS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ALLK
  • GNSS
  • Stock Information
  • Founded
  • ALLK 2012
  • GNSS 1992
  • Country
  • ALLK United States
  • GNSS United States
  • Employees
  • ALLK N/A
  • GNSS N/A
  • Industry
  • ALLK Biotechnology: Pharmaceutical Preparations
  • GNSS Consumer Electronics/Appliances
  • Sector
  • ALLK Health Care
  • GNSS Consumer Staples
  • Exchange
  • ALLK Nasdaq
  • GNSS Nasdaq
  • Market Cap
  • ALLK 101.0M
  • GNSS 116.8M
  • IPO Year
  • ALLK 2018
  • GNSS N/A
  • Fundamental
  • Price
  • ALLK $0.86
  • GNSS $2.92
  • Analyst Decision
  • ALLK Hold
  • GNSS Strong Buy
  • Analyst Count
  • ALLK 4
  • GNSS 3
  • Target Price
  • ALLK $1.67
  • GNSS $5.33
  • AVG Volume (30 Days)
  • ALLK 827.7K
  • GNSS 181.4K
  • Earning Date
  • ALLK 03-13-2025
  • GNSS 02-11-2025
  • Dividend Yield
  • ALLK N/A
  • GNSS N/A
  • EPS Growth
  • ALLK N/A
  • GNSS N/A
  • EPS
  • ALLK N/A
  • GNSS N/A
  • Revenue
  • ALLK N/A
  • GNSS $24,008,000.00
  • Revenue This Year
  • ALLK N/A
  • GNSS $136.42
  • Revenue Next Year
  • ALLK N/A
  • GNSS $56.53
  • P/E Ratio
  • ALLK N/A
  • GNSS N/A
  • Revenue Growth
  • ALLK N/A
  • GNSS N/A
  • 52 Week Low
  • ALLK $0.54
  • GNSS $1.51
  • 52 Week High
  • ALLK $1.69
  • GNSS $4.04
  • Technical
  • Relative Strength Index (RSI)
  • ALLK 35.16
  • GNSS 51.66
  • Support Level
  • ALLK $0.81
  • GNSS $2.57
  • Resistance Level
  • ALLK $1.00
  • GNSS $2.81
  • Average True Range (ATR)
  • ALLK 0.13
  • GNSS 0.17
  • MACD
  • ALLK -0.03
  • GNSS 0.06
  • Stochastic Oscillator
  • ALLK 8.43
  • GNSS 88.68

About ALLK Allakos Inc.

Allakos Inc is a clinical-stage company developing therapeutic antibodies that selectively target immunomodulatory receptors present on the surface of immune effector cells involved in allergic, inflammatory, and proliferative diseases. The company's lead program, AK006 targets Siglec-6, an inhibitory receptor expressed selectively on mast cells. Binding of AK006 to Siglec-6 is designed to activate the native inhibitory function of the receptor which in turn reduces mast cell activation.

About GNSS Genasys Inc.

Genasys Inc is a provider of Protective Communication solutions, including Genasys Protect software platform and Long Range Acoustic Device (LRAD). Its software platform receives information from variety of sensors and Internet-of-Things (IoT) inputs to collect real-time information on developing and active emergency situations. Genasys uses this information to create and disseminate alerts, warnings, notifications, and instructions through multiple channels before, during, and after public safety and enterprise threats, critical events, and other crisis situations. The Company operates in two business segments: Hardware and Software and its markets are North and South America, Europe, Middle East and Asia. Key revenue is generated from Hardware.

Share on Social Networks: